Business Description
ImmuPharma PLC
ISIN : GB0033711010
Total Employee Number:
7Description
ImmuPharma PLC focuses on the research, development, and commercialisation of pioneering and novel drugs in specialist therapeutic areas within the pharmaceutical industry. The company's pipeline products are P140, CDx, Kapiglucagon, BioAMB, and BioCIN.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.37 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 34.1 | |||||
3-Year EPS without NRI Growth Rate | 23.7 | |||||
3-Year FCF Growth Rate | 14.5 | |||||
3-Year Book Growth Rate | -50 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.57 | |||||
9-Day RSI | 48.25 | |||||
14-Day RSI | 46.65 | |||||
3-1 Month Momentum % | -2.14 | |||||
6-1 Month Momentum % | -30.39 | |||||
12-1 Month Momentum % | 124.24 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.52 | |||||
Quick Ratio | 1.52 | |||||
Cash Ratio | 1.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -14.7 | |||||
Shareholder Yield % | -5.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -1127.65 | |||||
ROA % | -122.24 | |||||
ROIC % | -315.14 | |||||
3-Year ROIIC % | -43.05 | |||||
ROC (Joel Greenblatt) % | -2937.56 | |||||
ROCE % | -1349.69 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 37.51 | |||||
EV-to-EBIT | -10.61 | |||||
EV-to-EBITDA | -10.78 | |||||
EV-to-FCF | -10.07 | |||||
Earnings Yield (Greenblatt) % | -9.43 | |||||
FCF Yield % | -9.76 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
ImmuPharma PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.004 | ||
| Beta | 10.1683 | ||
| 3-Year Sharpe Ratio | 0.59 | ||
| 3-Year Sortino Ratio | 3.42 | ||
| Volatility % | 420.81 | ||
| 14-Day RSI | 46.65 | ||
| 14-Day ATR (£) | 0.005981 | ||
| 20-Day SMA (£) | 0.039663 | ||
| 12-1 Month Momentum % | 124.24 | ||
| 52-Week Range (£) | 0.01386 - 0.194 | ||
| Shares Outstanding (Mil) | 623.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
ImmuPharma PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ImmuPharma PLC Stock Events
| Event | Date | Price (£) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2026 | 2026-08-06 | In 23 days | ||
| General meeting for 2025 | 2026-06-25 10:00 | 0.04 (-0.75%) | ||
| Annual report for 2025 | 2026-06-02 | 0.04 (-2.48%) | ||
| Fourth quarter earnings results for 2025 | 2026-05-27 | 0.05 (+1.81%) | ||
| Second quarter earnings results for 2025 | 2025-08-06 | 0.02 (+8.90%) | ||
| General meeting for 2024 | 2025-06-12 11:00 | 0.03 (+5.51%) | ||
| Annual report for 2024 | 2025-05-19 | 0.03 (-11.71%) | ||
| Fourth quarter earnings results for 2024 | 2025-05-19 | 0.03 (-11.71%) | ||
| Second quarter earnings results for 2024 | 2024-09-09 | 0.02 (+0.33%) |
Show
Entries
ImmuPharma PLC Frequently Asked Questions
What is ImmuPharma PLC(LSE:IMM)'s stock price today?
The current price of LSE:IMM is £0.04. The 52 week high of LSE:IMM is £0.19 and 52 week low is £0.01.
When is next earnings date of ImmuPharma PLC(LSE:IMM)?
The next earnings date of ImmuPharma PLC(LSE:IMM) is 2026-08-06 Est..
Does ImmuPharma PLC(LSE:IMM) pay dividends? If so, how much?
ImmuPharma PLC(LSE:IMM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ImmuPharma PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers